Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,431
archived clinical trials in
Back Pain

Making Better Lives: Patient-Focused Care for Low Back Pain (LBP)
Patient-Centered Versus Imaging-Directed Care for Older Veterans With Chronic LBP
Status: Enrolling
Updated:  12/31/1969
Hunter Holmes McGuire VA Medical Center, Richmond, VA
mi
from
Richmond, VA
Making Better Lives: Patient-Focused Care for Low Back Pain (LBP)
Patient-Centered Versus Imaging-Directed Care for Older Veterans With Chronic LBP
Status: Enrolling
Updated: 12/31/1969
Hunter Holmes McGuire VA Medical Center, Richmond, VA
mi
from
Richmond, VA
Click here to add this to my saved trials
Treatment of Veterans With Chronic Low Back Pain
Treatment of Veterans With Chronic Low Back Pain
Status: Enrolling
Updated:  12/31/1969
Michael E. DeBakey VA Medical Center, Houston, TX
mi
from
Houston, TX
Treatment of Veterans With Chronic Low Back Pain
Treatment of Veterans With Chronic Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Michael E. DeBakey VA Medical Center, Houston, TX
mi
from
Houston, TX
Click here to add this to my saved trials
Assessment of Chiropractic Treatment: Strength and Balance
Assessment of Chiropractic Treatment: Strength and Balance
Status: Enrolling
Updated:  12/31/1969
Naval Branch Health Clinic, NATTC
mi
from
Pensacola, FL
Assessment of Chiropractic Treatment: Strength and Balance
Assessment of Chiropractic Treatment: Strength and Balance
Status: Enrolling
Updated: 12/31/1969
Naval Branch Health Clinic, NATTC
mi
from
Pensacola, FL
Click here to add this to my saved trials
Investigation of Hypermobility, Biomarkers, and Pain Generators in Chronic Pain Patients
Investigation of Hypermobility, Biomarkers, and Pain Generators in Chronic Pain Patients
Status: Enrolling
Updated:  12/31/1969
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Investigation of Hypermobility, Biomarkers, and Pain Generators in Chronic Pain Patients
Investigation of Hypermobility, Biomarkers, and Pain Generators in Chronic Pain Patients
Status: Enrolling
Updated: 12/31/1969
University of Texas Health Science Center at Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Treatment of Back Pain Using Transcutaneous Magnetic Stimulation (TCMS)
Treatment of Back Pain Using Transcutaneous Magnetic Stimulation (TCMS)
Status: Enrolling
Updated:  12/31/1969
La Toya Stubbs
mi
from
Baltimore, MD
Treatment of Back Pain Using Transcutaneous Magnetic Stimulation (TCMS)
Treatment of Back Pain Using Transcutaneous Magnetic Stimulation (TCMS)
Status: Enrolling
Updated: 12/31/1969
La Toya Stubbs
mi
from
Baltimore, MD
Click here to add this to my saved trials
Feasibility of Using Functional Progression to Guide the Treatment of Adolescent Low Back Pain
Feasibility of Using Functional Progression to Guide the Treatment of Adolescent Low Back Pain
Status: Enrolling
Updated:  12/31/1969
Nationwide Children's Hospital Sports and Ortho PT East Broad
mi
from
Columbus, OH
Feasibility of Using Functional Progression to Guide the Treatment of Adolescent Low Back Pain
Feasibility of Using Functional Progression to Guide the Treatment of Adolescent Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Nationwide Children's Hospital Sports and Ortho PT East Broad
mi
from
Columbus, OH
Click here to add this to my saved trials
Feasibility of Using Functional Progression to Guide the Treatment of Adolescent Low Back Pain
Feasibility of Using Functional Progression to Guide the Treatment of Adolescent Low Back Pain
Status: Enrolling
Updated:  12/31/1969
Nationwide Children's Hospital Sports and Ortho PT Dublin
mi
from
Dublin, OH
Feasibility of Using Functional Progression to Guide the Treatment of Adolescent Low Back Pain
Feasibility of Using Functional Progression to Guide the Treatment of Adolescent Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Nationwide Children's Hospital Sports and Ortho PT Dublin
mi
from
Dublin, OH
Click here to add this to my saved trials
Feasibility of Using Functional Progression to Guide the Treatment of Adolescent Low Back Pain
Feasibility of Using Functional Progression to Guide the Treatment of Adolescent Low Back Pain
Status: Enrolling
Updated:  12/31/1969
Nationwide Children's Hospital Sports and Ortho PT New Albany
mi
from
New Albany, OH
Feasibility of Using Functional Progression to Guide the Treatment of Adolescent Low Back Pain
Feasibility of Using Functional Progression to Guide the Treatment of Adolescent Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Nationwide Children's Hospital Sports and Ortho PT New Albany
mi
from
New Albany, OH
Click here to add this to my saved trials
Feasibility of Using Functional Progression to Guide the Treatment of Adolescent Low Back Pain
Feasibility of Using Functional Progression to Guide the Treatment of Adolescent Low Back Pain
Status: Enrolling
Updated:  12/31/1969
Nationwide Children's Hospital Sports and Orthopedic PT Westerville location
mi
from
Westerville, OH
Feasibility of Using Functional Progression to Guide the Treatment of Adolescent Low Back Pain
Feasibility of Using Functional Progression to Guide the Treatment of Adolescent Low Back Pain
Status: Enrolling
Updated: 12/31/1969
Nationwide Children's Hospital Sports and Orthopedic PT Westerville location
mi
from
Westerville, OH
Click here to add this to my saved trials
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated:  12/31/1969
The University of California, San Diego
mi
from
La Jolla, CA
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated: 12/31/1969
The University of California, San Diego
mi
from
La Jolla, CA
Click here to add this to my saved trials
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated:  12/31/1969
The Spine Institute
mi
from
Santa Monica, CA
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated: 12/31/1969
The Spine Institute
mi
from
Santa Monica, CA
Click here to add this to my saved trials
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated:  12/31/1969
University of Colorado Hospital
mi
from
Aurora, CO
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated: 12/31/1969
University of Colorado Hospital
mi
from
Aurora, CO
Click here to add this to my saved trials
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated:  12/31/1969
University of Kansas Medical Center
mi
from
Kansas City, KA
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated: 12/31/1969
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated:  12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated: 12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated:  12/31/1969
Beaumont Health
mi
from
Royal Oak, MI
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated: 12/31/1969
Beaumont Health
mi
from
Royal Oak, MI
Click here to add this to my saved trials
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated:  12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated:  12/31/1969
Louis Stokes VA Medical Center
mi
from
Cleveland, OH
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated: 12/31/1969
Louis Stokes VA Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated:  12/31/1969
University Hospitals of Cleveland Medical Center
mi
from
Cleveland, OH
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated: 12/31/1969
University Hospitals of Cleveland Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated:  12/31/1969
Rhode Island Hospital
mi
from
Providence, RI
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated: 12/31/1969
Rhode Island Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated:  12/31/1969
Upstate Clinical Trials
mi
from
Spartanburg, SC
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated: 12/31/1969
Upstate Clinical Trials
mi
from
Spartanburg, SC
Click here to add this to my saved trials
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated:  12/31/1969
The Center for Pain Relief
mi
from
Charleston, WV
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated: 12/31/1969
The Center for Pain Relief
mi
from
Charleston, WV
Click here to add this to my saved trials
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated:  12/31/1969
Genesis Research Services
mi
from
Broadmeadow,
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated: 12/31/1969
Genesis Research Services
mi
from
Broadmeadow,
Click here to add this to my saved trials
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated:  12/31/1969
Indiana Spine Group
mi
from
Carmel, IN
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated: 12/31/1969
Indiana Spine Group
mi
from
Carmel, IN
Click here to add this to my saved trials
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated:  12/31/1969
OrthoIndy
mi
from
Indianapolis, IN
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated: 12/31/1969
OrthoIndy
mi
from
Indianapolis, IN
Click here to add this to my saved trials
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated:  12/31/1969
The Center for Clinical Research
mi
from
Winston-Salem, NC
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated: 12/31/1969
The Center for Clinical Research
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated:  12/31/1969
Northwest Orthopaedic Specialists
mi
from
Spokane, WA
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain
ReActiv8 Implantable Neurostimulation System for Chronic Low Back Pain (ReActiv8-B)
Status: Enrolling
Updated: 12/31/1969
Northwest Orthopaedic Specialists
mi
from
Spokane, WA
Click here to add this to my saved trials
MOBile Instruction for Low Back Pain (MOBIL)
Brief Mobile Education at the Point of Care to Influence Healthcare Decisions Related Low Back Pain Management in Primary Care
Status: Enrolling
Updated:  12/31/1969
Brooke Army Medical Center
mi
from
San Antonio, TX
MOBile Instruction for Low Back Pain (MOBIL)
Brief Mobile Education at the Point of Care to Influence Healthcare Decisions Related Low Back Pain Management in Primary Care
Status: Enrolling
Updated: 12/31/1969
Brooke Army Medical Center
mi
from
San Antonio, TX
Click here to add this to my saved trials
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated:  12/31/1969
Parkway Medical Center
mi
from
Birmingham, AL
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated: 12/31/1969
Parkway Medical Center
mi
from
Birmingham, AL
Click here to add this to my saved trials
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated:  12/31/1969
Boyett Health Services
mi
from
Hamilton, AL
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated: 12/31/1969
Boyett Health Services
mi
from
Hamilton, AL
Click here to add this to my saved trials
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated:  12/31/1969
River Cities Clinical Research Center
mi
from
Shreveport, LA
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated: 12/31/1969
River Cities Clinical Research Center
mi
from
Shreveport, LA
Click here to add this to my saved trials
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated:  12/31/1969
Hassman Research Institute
mi
from
Berlin, NJ
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated: 12/31/1969
Hassman Research Institute
mi
from
Berlin, NJ
Click here to add this to my saved trials
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated:  12/31/1969
National Centers for Pain Management and Research
mi
from
Vestavia Hills, AL
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated: 12/31/1969
National Centers for Pain Management and Research
mi
from
Vestavia Hills, AL
Click here to add this to my saved trials
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated:  12/31/1969
Elite Clinical Studies
mi
from
Phoenix, AZ
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated: 12/31/1969
Elite Clinical Studies
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated:  12/31/1969
Phoenix Clinical
mi
from
Phoenix, AZ
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated: 12/31/1969
Phoenix Clinical
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated:  12/31/1969
Noesis Pharma
mi
from
Phoenix, AZ
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated: 12/31/1969
Noesis Pharma
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated:  12/31/1969
Arizona Research Center
mi
from
Phoenix, AZ
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated: 12/31/1969
Arizona Research Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated:  12/31/1969
MD Studies, Inc.
mi
from
Fountain Valley, CA
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated: 12/31/1969
MD Studies, Inc.
mi
from
Fountain Valley, CA
Click here to add this to my saved trials
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated:  12/31/1969
Neuro-Pain Medical Center
mi
from
Fresno, CA
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated: 12/31/1969
Neuro-Pain Medical Center
mi
from
Fresno, CA
Click here to add this to my saved trials
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated:  12/31/1969
Alliance Research Centers
mi
from
Laguna Hills, CA
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated: 12/31/1969
Alliance Research Centers
mi
from
Laguna Hills, CA
Click here to add this to my saved trials
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated:  12/31/1969
Clinical Trials Research
mi
from
Lincoln, CA
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated: 12/31/1969
Clinical Trials Research
mi
from
Lincoln, CA
Click here to add this to my saved trials
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated:  12/31/1969
Catalina Research Institute, LLC
mi
from
Montclair, CA
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated: 12/31/1969
Catalina Research Institute, LLC
mi
from
Montclair, CA
Click here to add this to my saved trials
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated:  12/31/1969
Allied Clinical Research, LLC
mi
from
Sacramento, CA
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated: 12/31/1969
Allied Clinical Research, LLC
mi
from
Sacramento, CA
Click here to add this to my saved trials
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated:  12/31/1969
Care Practice
mi
from
San Francisco, CA
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated: 12/31/1969
Care Practice
mi
from
San Francisco, CA
Click here to add this to my saved trials
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated:  12/31/1969
Syrentis Clinical Research
mi
from
Santa Ana, CA
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated: 12/31/1969
Syrentis Clinical Research
mi
from
Santa Ana, CA
Click here to add this to my saved trials
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated:  12/31/1969
Universal Pain Management Group
mi
from
Valencia, CA
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated: 12/31/1969
Universal Pain Management Group
mi
from
Valencia, CA
Click here to add this to my saved trials
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated:  12/31/1969
Tampa Pain Relief Center-Brandon
mi
from
Brandon, FL
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated: 12/31/1969
Tampa Pain Relief Center-Brandon
mi
from
Brandon, FL
Click here to add this to my saved trials
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated:  12/31/1969
International Research Partners, LLC.
mi
from
Doral, FL
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated: 12/31/1969
International Research Partners, LLC.
mi
from
Doral, FL
Click here to add this to my saved trials
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated:  12/31/1969
Dr Vijapura and Associates
mi
from
Jacksonville, FL
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated: 12/31/1969
Dr Vijapura and Associates
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated:  12/31/1969
Florida Institute of Medical Research
mi
from
Jacksonville, FL
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated: 12/31/1969
Florida Institute of Medical Research
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated:  12/31/1969
Lake Howell Health Center
mi
from
Maitland, FL
Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Enriched-Enrollment Withdrawal, Multicenter Study to Evaluate the Efficacy and Safety of a Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Subjects With Moderate to Severe Chronic Low Back Pain Currently Treated With Daily Opioids
Status: Enrolling
Updated: 12/31/1969
Lake Howell Health Center
mi
from
Maitland, FL
Click here to add this to my saved trials